168幸运飞飞艇官网号码下载_幸运飞行艇结果官网记录查询-飞艇168官方开奖历史记录号码 Tailoring Your Integrated Aseptic Solutions.

Your Success, Our Commitment.

We specialize in the development of GMP consultancy, engineering & construction projects, and integrated process equipment. We combine our knowledge and in-house technologies to provide optimal solutions with a high added value to companies associated with Life & Health Sciences (pharmaceutical & biotechnology, healthcare, cosmetic, veterinary, and food & beverage industries), as well as hospitals, laboratories & research centres.

幸运飞行艇开奖官网结果查询 幸运飞飞艇历史号码开奖记录 Latest News

07-06-2024

Telstar starts a new stage  

Telstar will join the Germany-based company following the transaction announced by Azbil Corporation and Syntegon.   Telstar will become part of…
06-06-2024

Telstar to Unveil Advanced GMP Digitization and Aseptic Process Solutions at Achema 2024

At Achema (Frankfurt, Germany, 10-14 June 2024), we will be unveiling Telstar’s latest innovations and services designed to enhance efficiency…
22-03-2024

Telstar Insights at Interphex 2024

At Interphex (New York April 16-18, 2024), we will be promoting the innovative Pharma 4.0 IoT Data platform for predictive…
20-03-2024

Telstar’s production centre in China has moved into a new modern higher capacity facility.

Our centre in China expands production capacity with a move to new premises in the district of Lingang, in Shanghai,…
11-03-2024

A new dual mode isolator system by Telstar at Pharma Congress 2024

A new dual mode Isolator system capable of operation for either containment or aseptic purposes will be promoted at Pharma…

Telstar Worldwide Presence

Our global network centres, in collaboration with agents worldwide, work together in close association with the global centres of excellence and the rest of the subsidiaries to offer an immediate and successful response to international markets

USA Mexico Brazil Spain Portugal UK France Italy Bangladesh India China Japan

Fairs and Events

16-01-2024

Farmaforum

Farmaforum 2024, Forum of the Pharmaceutical, Biopharmaceutical, and Laboratory Technologies Industry, celebrates its seventh edition in Madrid. In its six…

Carbon Footprint

The quantification of direct and indirect greenhouse gas (GHG) emissions has been carried out following the ISO 14064 standard, based on the GHG Protocol. Our GHG inventory includes direct combustion emissions (Scope 1), indirect emissions from electricity consumption (Scope 2), as well as other indirect emissions, commonly known as Scope 3.

6%

Scope 1

0%

Scope 2

94%

Scope 3

9.777,04 tnCO2e from last twelve month